Effective Jan. 1, 2026, the long-standing National Patient Safety Goals (NPSGs) shifted to the National
Performance
Goals (NPGs) for hospital and critical access hospital accreditation programs. These are clearly defined
measurable
goals that help hospitals and critical access hospitals improve safety, quality and outcomes—and it’s more than a
name change. This shift signals a deeper evolution in how hospitals are evaluated, expanding from a focus on
preventing harm to achieving measurable, organization-wide performance outcomes. As The Joint Commission’s focus
shifts from compliance-based safety requirements to performance-driven goals, healthcare leaders will need to more
deliberately align sourcing strategy with clinical quality, patient safety and enterprise-wide performance outcomes.
Why this matters
Historically, sourcing has centered on cost control, standardization and regulatory compliance. However, as
healthcare organizations transition to the NPGs, sourcing decisions now must include measurable clinical outcomes,
operational reliability and workforce stability. In this new framework, sourcing becomes a strategic enabler of
quality and safety—directly impacting accreditation readiness, patient outcomes and enterprise risk. For healthcare
leaders, this means procurement strategy is now inseparable from performance strategy, and organizations that don’t
prioritize this shift risk patient harm and loss of accreditation.
A leadership imperative
Building and sustaining a culture of safety requires more than policy. It requires deliberate leadership decisions
that shape the environment in which care is delivered, including how clinical and sourcing strategies are developed
and aligned. As a result, leadership accountability moves to the forefront. When strategy, sourcing and clinical
quality are intentionally connected, organizations are better positioned to improve measurable NPG outcomes,
strengthen patient care and sustain performance excellence across the enterprise.
Here are four sourcing strategies organizations should consider:
- Evaluate clinical reliability and error prevention as core criteria. Within the request for proposal
(RFP)
process, evaluate products and services not only on specifications and cost, but also on their ability to
support clinical reliability and reduce risk across high-risk workflows. Sourcing criteria that emphasize
delivering the right care to the right patient at the right time, along with standardization and consistent
performance, help enable reliable care delivery throughout clinical settings. Evaluating vendors based on
demonstrated performance, such as reductions in medication errors or imaging-related safety events, directly
aligns sourcing decisions with NPG expectations for accuracy and reliability. Embedding reliability
intentionally into sourcing decisions—as opposed to creating individual workarounds—increases the likelihood of
performance success.
- Prioritize safety and infection prevention. The sourcing process increasingly plays a critical role in
reducing
preventable harm by incorporating safety and infection prevention considerations into contracting decisions.
Evaluating safety-engineered design, environmental factors and evidence-based infection reduction during
sourcing enables organizations to proactively mitigate risk. Products and technologies that contribute to safer
care environments support both patient and workforce safety, which reinforces performance expectations related
to reliability and harm reduction. An approach focused on safety and harm prevention strengthens resilience and
minimizes downstream clinical and operational burden.
- Support equitable, patient-centered care. Clinical and quality review within the RFP process plays an
important
role in ensuring that sourced solutions support equitable, patient-centered care across diverse populations.
Incorporating evaluation criteria related to usability, accessibility, communication and patient engagement
helps organizations assess how well products and services meet the needs of patients and care teams. Sourcing
decisions that account for health literacy, language access and patient experience can contribute to improved
outcomes, increased trust and more consistent care delivery. When equity and patient-centered design
considerations are integrated into sourcing decisions, organizations are better positioned to support NPG
expectations related to outcomes and informed care.
- Commit to supplier partnerships that enable performance and accountability. Suppliers that demonstrate a
commitment to partnership and align with organizational objectives, support
clinical and operational priorities, and engage collaboratively beyond contract award are a value-add to a
healthcare organization’s performance strategy and goals. Suppliers that actively collaborate with clinical,
quality and supply chain leaders are better positioned to support organizations as performance expectations
evolve. Sourcing decisions emphasizing long-term partnership, alignment and responsiveness equip healthcare
leaders to translate sourcing strategies into meaningful improvements in clinical, quality, safety and overall
organizational performance.
The call for the new NPGs is to rise above requirements and enhance enterprise-wide performance. As healthcare
organizations prepare for this new transition, leaders must view this change as not simply a regulatory requirement
but as a catalyst for performance transformation. Integrating the NPGs into both clinical and sourcing
decision-making allows organizations to more intentionally align quality, safety and operational priorities. Those
that embed these goals into their clinical and sourcing strategies will set the standard for quality, safety and
performance excellence.